|
MKNK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.97550000000347E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.583000E-03 |
| Normal-vs-Stage2 |
1.779310E-03 |
| Normal-vs-Stage3 |
3.259800E-02 |
| Normal-vs-Stage4 |
3.536000E-01 |
| Stage1-vs-Stage2 |
3.633900E-02 |
| Stage1-vs-Stage3 |
8.771400E-01 |
| Stage1-vs-Stage4 |
7.334600E-01 |
| Stage2-vs-Stage3 |
1.409170E-01 |
| Stage2-vs-Stage4 |
7.705200E-01 |
| Stage3-vs-Stage4 |
7.693600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.552000E-04 |
| Normal-vs-AfricanAmerican |
1.415880E-03 |
| Normal-vs-Asian |
7.285900E-02 |
| Caucasian-vs-AfricanAmerican |
6.175000E-01 |
| Caucasian-vs-Asian |
5.083500E-02 |
| AfricanAmerican-vs-Asian |
9.308200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.022400E-04 |
| Normal-vs-Female |
4.567400E-04 |
| Male-vs-Female |
6.614600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.179000E-03 |
| Normal-vs-Extreme_Weight |
5.080900E-03 |
| Normal-vs-Obese |
2.936000E-02 |
| Normal-vs-Extreme_Obese |
2.361900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.546800E-01 |
| Normal_Weight-vs-Obese |
2.048800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.179600E-01 |
| Extreme_Weight-vs-Obese |
5.644400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.635000E-01 |
| Obese-vs-Extreme_Obese |
4.429400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.983000E-04 |
| Normal-vs-Age(41-60Yrs) |
9.78710000000271E-05 |
| Normal-vs-Age(61-80Yrs) |
1.217250E-03 |
| Normal-vs-Age(81-100Yrs) |
8.399800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.709000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.527700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.102300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.392600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.369900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.149390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.444400E-04 |
| Normal-VS-Type2 PRCC |
1.162990E-01 |
| Normal-VS-KIRP CIMP |
4.421900E-04 |
| Normal-VS-Unclassified PRCC |
1.826490E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.158440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.058760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.604810E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.376110E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.830100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.153600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.188600E-04 |
| Normal-vs-N1 |
3.209800E-02 |
| Normal-vs-N2 |
8.392800E-01 |
| N0-vs-N1 |
5.966400E-01 |
| N0-vs-N2 |
3.917800E-01 |
| N1-vs-N2 |
4.886200E-01 |
|
|
